X34 Stock Overview
Provides home health and hospice services in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 6/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
Enhabit, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$6.85 |
| 52 Week High | US$10.60 |
| 52 Week Low | US$6.10 |
| Beta | 1.38 |
| 11 Month Change | 5.38% |
| 3 Month Change | -4.86% |
| 1 Year Change | -22.16% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -48.50% |
Recent News & Updates
Recent updates
Shareholder Returns
| X34 | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | -3.5% | 1.0% | -0.5% |
| 1Y | -22.2% | 19.2% | 8.3% |
Return vs Industry: X34 underperformed the German Healthcare industry which returned 19.2% over the past year.
Return vs Market: X34 underperformed the German Market which returned 8.3% over the past year.
Price Volatility
| X34 volatility | |
|---|---|
| X34 Average Weekly Movement | 8.0% |
| Healthcare Industry Average Movement | 3.9% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 11.0% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: X34's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: X34's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1998 | 10,800 | Barb Jacobsmeyer | www.ehab.com |
Enhabit, Inc. provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer’s disease, low vision, spinal stenosis, Parkinson’s disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services. The company offers hospice services, including pain and symptom management, palliative and dietary counseling, social worker visits, spiritual counseling, and bereavement counseling services to meet the individual physical, emotional, spiritual, and psychosocial needs of terminally ill patients and their families.
Enhabit, Inc. Fundamentals Summary
| X34 fundamental statistics | |
|---|---|
| Market cap | €351.07m |
| Earnings (TTM) | -€110.76m |
| Revenue (TTM) | €985.24m |
0.3x
P/S Ratio-3.1x
P/E RatioIs X34 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| X34 income statement (TTM) | |
|---|---|
| Revenue | US$1.04b |
| Cost of Revenue | US$531.20m |
| Gross Profit | US$506.00m |
| Other Expenses | US$622.60m |
| Earnings | -US$116.60m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -2.32 |
| Gross Margin | 48.79% |
| Net Profit Margin | -11.24% |
| Debt/Equity Ratio | 86.8% |
How did X34 perform over the long term?
See historical performance and comparison